This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rose, J. R. Articles by Rossignol, D. P. Search for Related Content PubMed PubMed Citation Articles by Rose, J. R. Articles by Rossignol, D. P.

 Previous Article  |  Next Article 

Infect. Immun., Mar 1995, 833-839, Vol 63, No. 3
Copyright © 1995, American Society for Microbiology

Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs

JR Rose, WJ Christ, JR Bristol, T Kawata and DP Rossignol
Section of Biology, Eisai Research Institute, Andover, Massachusetts 01810-2441.

Lipid A from the photosynthetic bacterium Rhodobacter sphaeroides (RSLA) has been previously shown to antagonize many of the effects of endotoxins from more pathogenic gram-negative bacteria. We have reported on the synthesis of the proposed structure of RSLA and determined that bacterially derived RSLA is not identical to its proposed structure (W.J. Christ, P. D. McGuinness, O. Asano, Y. Wang, M. A. Mullarkey, M. Perez, L. D. Hawkins, T. A. Blythe, G. R. Dubuc, and A. L. Robidoux, J. Am. Chem. Soc. 116:3637-3638, 1994). Here we report results of analyzing the antagonistic and agonistic activities of bacterially derived RSLA in comparison with the activities of chemically synthesized material of the proposed structure of RSLA and analogs. Results indicated that all compounds were approximately equally potent at inhibiting endotoxin-induced release of tumor necrosis factor alpha from human monocytes and human whole blood as well as endotoxin-induced generation of nitric oxide in murine macrophages. In addition, all compounds were of equivalent potencies at inhibiting the binding of 125I-labelled lipopolysaccharide derivatized with 2-(p-azido-salicylamido) ethyl-1-3'-dithiopropionate to murine macrophages. Higher concentrations of bacterially derived RSLA (10 to 100 microM) were agonistic in human and murine assays. In gamma interferon-treated murine macrophages, agonism was exhibited at concentrations as low as 100 nM. In contrast, all synthetic materials were either dramatically less agonistic or devoid of agonistic activity when tested at concentrations as high as 100 microM. It is possible either that bacterially derived RSLA contains a small amount of a highly agonistic impurity or that the agonistic activity of RSLA is intrinsic to its molecular structure. In either case, these biological results support our previous report concluding that biologically derived RSLA is not identical to synthetic material of its proposed structure.

This article has been cited by other articles:

• Duenas, A. I, Aceves, M., Orduna, A., Diaz, R., Sanchez Crespo, M., Garcia-Rodriguez, C. (2006). Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS. Int Immunol 18: 785-795 [Abstract] [Full Text]  
• Triantafilou, M., Triantafilou, K. (2005). Invited review: The dynamics of LPS recognition: complex orchestration of multiple receptors. Innate Immunity 11: 5-11 [Abstract]  
• Rossignol, D. P., Wasan, K. M., Choo, E., Yau, E., Wong, N., Rose, J., Moran, J., Lynn, M. (2004). Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipoprotein Distribution of Eritoran (E5564) during Continuous Intravenous Infusion into Healthy Volunteers. Antimicrob. Agents Chemother. 48: 3233-3240 [Abstract] [Full Text]  
• Wong, Y. N., Rossignol, D., Rose, J. R., Kao, R., Carter, A., Lynn, M. (2003). Safety, Pharmacokinetics, and Pharmacodynamics of E5564, a Lipid A Antagonist, during an Ascending Single-Dose Clinical Study. J Clin Pharmacol 43: 735-742 [Abstract] [Full Text]  
• Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., Rossignol, D. P. (2003). Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist. J. Pharmacol. Exp. Ther. 304: 1093-1102 [Abstract] [Full Text]  
• Rossignol, D. P., Lynn, M. (2002). Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue. Innate Immunity 8: 483-488 [Abstract]  
• Rose, J. R., Mullarkey, M. A., Christ, W. J., Hawkins, L. D., Lynn, M., Kishi, Y., Wasan, K. M., Peteherych, K., Rossignol, D. P. (2000). Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins. Antimicrob. Agents Chemother. 44: 504-510 [Abstract] [Full Text]  
• Barclay, N. G., Spurrell, J. C. L., Bruno, T. F., Storey, D. G., Woods, D. E., Mody, C. H. (1999). Pseudomonas aeruginosa Exoenzyme S Stimulates Murine Lymphocyte Proliferation In Vitro. Infect. Immun. 67: 4613-4619 [Abstract] [Full Text]  
• Kobayashi, S., Kawata, T., Kimura, A., Miyamoto, K., Katayama, K., Yamatsu, I., Rossignol, D. P., Christ, W. J., Kishi, Y. (1998). Suppression of Murine Endotoxin Response by E5531, a Novel Synthetic Lipid A Antagonist. Antimicrob. Agents Chemother. 42: 2824-2829 [Abstract] [Full Text]